Appointment booking for Dr. Daniel Constance, MD is currently not available.Dr. Daniel Constance, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Daniel Constance, MD (he/him) is a Sports Medicine Doctor, Internist in Lawton, OK with over 17 years of experience. What is your opinion of Dr. Daniel Constance, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Daniel Constance, MD has received over $595 which includes payments from the following companies:
$124.15 from LILLY USA, LLC
$77.89 from Flexion Therapeutics, Inc.
$72.97 from Bioventus LLC
$59.57 from Takeda Pharmaceuticals America, Inc.
$38.19 from sanofi-aventis U.S. LLC
$33.73 from DePuy Synthes Sales Inc.
$24.59 from FOREST PHARMACEUTICALS, INC.
$22.59 from AstraZeneca Pharmaceuticals LP
$21.22 from E.R. Squibb & Sons, L.L.C.
$20.63 from Pacira Pharmaceuticals Incorporated
$20.62 from Allergan Inc.
$12.19 from Janssen Pharmaceuticals, Inc
$11.73 from Daiichi Sankyo Inc.
$11.21 from Egalet US Inc
$11.11 from Iroko Pharmaceuticals, LLC
$11.04 from Abbott Laboratories
$11.01 from Eisai Inc.
$10.85 from Osiris Therapeutics Inc.
Payments received by Dr. Daniel Constance, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!